Oramed’s Chinese Partner, HTIT, Successfully Completes Phase 3 Oral Insulin Clinical Trial/Submits Marketing Authorization Application in China
Oramed Pharmaceuticals. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com) strategic partner, Hefei Tianhui Biotechnology (HTIT), has completed its Phase III trials of oral insulin for type 2
Gamida Cell’s Allogeneic Cell Therapy Omisirge® Receives FDA Approval
Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, has recently announced that the U.S. Food and Drug
VLX Ventures Ventures Launches 4 New Biotech Start-Ups
VLX Ventures has recently announced the launch of 4 new biotech and computational bilgy start-ups, all spearheaded by female CEOs. The four start-ups center around
Nanox.AI Expands Footprint Through New Global Partnership with Ferrum Health!
NANO-X IMAGING LTD (“Nanox” Nasdaq: NNOX), an innovative medical imaging technology company, announced that its deep-learning medical imaging analytics subsidiary, Nanox.AI, has entered into a
Israeli Health Ministry New Platform “Kineret” Providing Real-Time Clinical Data from Israel’s Hospitals
The Directorate of Government Medical Centers at the Ministry of Health has launched a powerful, new resource, Kineret Data Lake, that includes ~6.5M medical EMR records,
Itay&Beyond Raises $2M for Drug Development & Diagnostics for Autistic Spectrum Disorders Groundbreaking Technology
With 2M$ gained through pre-seed funding, Itay&Beyond has initiated the recruitment of 200 low-functioning individuals with Autistic Spectrum Disorder (ASD) to develop their drug discovery
Alpha Tau Launches Alpha DaRT Treatment in Multiple Advanced Cancer Clinical Trials
Jerusalem-based Alpha Tau Medical Ltd. “Alpha Tau”, (NASDAQ: DRTS, DRTSW), has announced that up to 86 patients are to be enrolled in the U.S., Canada,
BioNTech Heads to Jerusalem to Build mRNA Vax Plant
German biotechnology company BioNTech, which developed the Covid-19 vaccine marketed by Pfizer, will develop the drugs and vaccines using mRNA technology in the Har Hotzvim
Neteera Completes $13 Million Investment Series B Funding Round!
Israeli startup Neteera Technologies, which is headquartered in Jerusalem, has closed their B-round in deteriorating market conditions a $13M round giving them a significant runway
